Ann Cullinane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ann Cullinane has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Sarah Gildea
Virology Unit, The Irish Equine Centre, Naas, Co. Kildare, Ireland
6 shared publicationsSean Arkins
Department of Life Sciences University of Limerick Limerick Ireland
6 shared publications- Cathal Walsh
TCD Biostatistics Unit, Discipline of Public Health and Primary Care, School of Medicine, Trinity College Dublin, Dublin, Ireland
5 shared publications Michelle Quinlivan
Virology Unit The Irish Equine Centre Johnstown Naas Co. Kildare Ireland
4 shared publicationsS. Gildea
Virology Unit, The Irish Equine Centre, Johnstown, Naas, Co. Kildare, Ireland
4 shared publicationsMaura Nelly
Virology Unit The Irish Equine Centre Johnstown Naas Co. Kildare Ireland
2 shared publications
Latest Publications
- Open Access
- 2 July 2016
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 10 (5) , 433-437
Concurrent vaccination against equine influenza and equine herpesvirus – a practical approach
There is a lack of information concerning concurrent administration of vaccines against equine influenza virus (EIV) and equine herpesvirus 1 and 4 (EHV-1/4). The primary objective of this study was to determine the impact of the concurrent use of EIV and EHV-1/4 vaccines in Thoroughbred racehorses on their humoral immune response to EIV. This study was carried out on a population of 30 horses using an inactivated whole-virus EIV vaccine and an inactivated EHV-1/4 vaccine. Horses were randomly allocated to vaccination group A or B. Horses in group A were vaccinated against EIV and EHV-1/4 2 weeks apart. Horses in group B were vaccinated against EIV and EHV-1/4 on the same day. Whole-blood samples were collected on the day of vaccination and 2 weeks and 6 weeks post-vaccination. Antibody levels against EIV and EHV-1/4 were measured using the single radial haemolysis and serum neutralisation test, respectively. The pattern of EIV antibody response post-vaccination was similar for both groups. Highest EIV antibody levels were recorded 2 weeks post-vaccination, and a significant decrease in antibody level was observed 4 weeks later. Horses in group B demonstrated a significantly higher EIV antibody response post-vaccination. Overall, there was no significant difference in EHV-1/4 antibody response between the two groups post-vaccination. In this study, concurrent vaccination against EIV and EHV-1/4 increased the response to EIV and did not compromise the humoral immune response to EHV-1/4.
- 2 July 2016
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 10 (5) , 433-437
Open AccessConcurrent vaccination against equine influenza and equine herpesvirus – a practical approach
There is a lack of information concerning concurrent administration of vaccines against equine influenza virus (EIV) and equine herpesvirus 1 and 4 (EHV-1/4). The primary objective of this study was to determine the impact of the concurrent use of EIV and EHV-1/4 vaccines in Thoroughbred racehorses on their humoral immune response to EIV. This study was carried out on a population of 30 horses using an inactivated whole-virus EIV vaccine and an inactivated EHV-1/4 vaccine. Horses were randomly allocated to vaccination group A or B. Horses in group A were vaccinated against EIV and EHV-1/4 2 weeks apart. Horses in group B were vaccinated against EIV and EHV-1/4 on the same day. Whole-blood samples were collected on the day of vaccination and 2 weeks and 6 weeks post-vaccination. Antibody levels against EIV and EHV-1/4 were measured using the single radial haemolysis and serum neutralisation test, respectively. The pattern of EIV antibody response post-vaccination was similar for both groups. Highest EIV antibody levels were recorded 2 weeks post-vaccination, and a significant decrease in antibody level was observed 4 weeks later. Horses in group B demonstrated a significantly higher EIV antibody response post-vaccination. Overall, there was no significant difference in EHV-1/4 antibody response between the two groups post-vaccination. In this study, concurrent vaccination against EIV and EHV-1/4 increased the response to EIV and did not compromise the humoral immune response to EHV-1/4.
- 24 November 2014
- Published by Wiley in Equine Veterinary Journal
- Vol. 47 (6) , 662-666
The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses
Summary: Reasons for performing study: More knowledge of equine influenza ( EI ) vaccine usage in training yards and the factors that influence serological response to vaccination are required to determine evidence‐based vaccination strategies. Objectives: The aim of this study was to ascertain the vaccination history of a population of Thoroughbred racehorses and identify factors that impacted on their antibody titres against EI . Study design: Observational field study. Methods: The study population consisted of 102 vaccinated Thoroughbred horses in training on a single premises. The vaccination histories recorded in their official passports were analysed. Blood samples for serological testing were collected by the veterinary surgeon one month after booster vaccination with P roteq F lu‐ T e. Antibodies against EI were measured by single radial haemolysis ( SRH ). Multivariate statistical analysis was undertaken to determine the predictors of SRH antibody titres. Results: There was a strong correlation between age and number of vaccine doses received. Over 70% of horses received their first vaccine dose between ages 6 and 12 months. On average, horses had received 6 vaccine doses and the mean interval between booster vaccinations was 7.7 months. The majority of horses (95%) received more than one influenza vaccine product while 32% had received 3 vaccine products. Significantly higher antibody levels were observed in females than males and there was a significant association between the number of vaccine products administered and antibody levels. In contrast, a negative association between number of vaccine doses and SRH antibody level was demonstrated. Conclusions: Important predictors of EI antibody titres in racehorses were sex, number of vaccine doses received and number of different vaccine products administered.
- 24 November 2014
- Published by Wiley in Equine Veterinary Journal
- Vol. 47 (6) , 662-666
The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses
Summary: Reasons for performing study: More knowledge of equine influenza ( EI ) vaccine usage in training yards and the factors that influence serological response to vaccination are required to determine evidence‐based vaccination strategies. Objectives: The aim of this study was to ascertain the vaccination history of a population of Thoroughbred racehorses and identify factors that impacted on their antibody titres against EI . Study design: Observational field study. Methods: The study population consisted of 102 vaccinated Thoroughbred horses in training on a single premises. The vaccination histories recorded in their official passports were analysed. Blood samples for serological testing were collected by the veterinary surgeon one month after booster vaccination with P roteq F lu‐ T e. Antibodies against EI were measured by single radial haemolysis ( SRH ). Multivariate statistical analysis was undertaken to determine the predictors of SRH antibody titres. Results: There was a strong correlation between age and number of vaccine doses received. Over 70% of horses received their first vaccine dose between ages 6 and 12 months. On average, horses had received 6 vaccine doses and the mean interval between booster vaccinations was 7.7 months. The majority of horses (95%) received more than one influenza vaccine product while 32% had received 3 vaccine products. Significantly higher antibody levels were observed in females than males and there was a significant association between the number of vaccine products administered and antibody levels. In contrast, a negative association between number of vaccine doses and SRH antibody level was demonstrated. Conclusions: Important predictors of EI antibody titres in racehorses were sex, number of vaccine doses received and number of different vaccine products administered.
- 15 August 2014
- Published by Wiley in Equine Veterinary Education
- Vol. 26 (9) , 456-457
Equine influenza and air transport
- 15 August 2014
- Published by Wiley in Equine Veterinary Education
- Vol. 26 (9) , 456-457
Equine influenza and air transport
- Open Access
- 7 February 2014
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 8 (3) , 376-383
The evaluation of three diagnostic tests for the detection of equine influenza nucleoprotein in nasal swabs
Background: Equine influenza (EI) is a highly contagious respiratory disease of horses.Objectives: The aim of this study was to evaluate two rapid antigen detection kits (Directigen or DFA, and Espline) and a commercial ELISA for the detection of EI nucleoprotein in nasal swabs.Method: Nasal swab samples from naturally and experimentally infected horses were used to compare the sensitivity and specificity of these assays to virus isolation (VI) and real‐time RT‐PCR.Results: If real‐time RT‐PCR was considered as the gold standard, the sensitivity of the other tests in field samples was 68% (DFA), 35% (ELISA), 29% (Espline), and 9% (VI). These tests had 100% specificity when compared to real‐time RT‐PCR. A receiver operating characteristic (ROC) curve indicated that decreasing the cutoff of the ELISA would increase sensitivity with some loss of specificity. In samples from experimentally infected horses, the sensitivity of the tests compared with real‐time RT‐PCR was 69% (VI), 27% (DFA), 6% (Espline), and 2% (ELISA). The specificity was 100% for Espline and ELISA and 95% for VI and DFA.Conclusions: This study illustrated that DFA is the most sensitive antigen detection test evaluated for the diagnosis of EI and that it can detect virus in some subclinical infected and vaccinated horses. The results suggest that DFA is a useful adjunct to laboratory tests and may be effective as a screening test in a quarantine station or similar facility where horses are monitored daily.
- 7 February 2014
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 8 (3) , 376-383
Open AccessThe evaluation of three diagnostic tests for the detection of equine influenza nucleoprotein in nasal swabs
Background: Equine influenza (EI) is a highly contagious respiratory disease of horses.Objectives: The aim of this study was to evaluate two rapid antigen detection kits (Directigen or DFA, and Espline) and a commercial ELISA for the detection of EI nucleoprotein in nasal swabs.Method: Nasal swab samples from naturally and experimentally infected horses were used to compare the sensitivity and specificity of these assays to virus isolation (VI) and real‐time RT‐PCR.Results: If real‐time RT‐PCR was considered as the gold standard, the sensitivity of the other tests in field samples was 68% (DFA), 35% (ELISA), 29% (Espline), and 9% (VI). These tests had 100% specificity when compared to real‐time RT‐PCR. A receiver operating characteristic (ROC) curve indicated that decreasing the cutoff of the ELISA would increase sensitivity with some loss of specificity. In samples from experimentally infected horses, the sensitivity of the tests compared with real‐time RT‐PCR was 69% (VI), 27% (DFA), 6% (Espline), and 2% (ELISA). The specificity was 100% for Espline and ELISA and 95% for VI and DFA.Conclusions: This study illustrated that DFA is the most sensitive antigen detection test evaluated for the diagnosis of EI and that it can detect virus in some subclinical infected and vaccinated horses. The results suggest that DFA is a useful adjunct to laboratory tests and may be effective as a screening test in a quarantine station or similar facility where horses are monitored daily.
- 29 January 2014
- Published by Wiley in Equine Veterinary Journal
- Vol. 46 (6) , 669-673
Comparison of primary vaccination regimes for equine influenza: Working towards an evidence‐based regime
Summary: Reasons for performing study: Vaccination is crucial to the control of equine influenza ( EI ). The study was conducted in an effort to lay the groundwork for achieving international harmonisation of regulatory requirements based on scientific evidence of performance of different vaccination regimes. Objectives: To evaluate the effectiveness of 3 different primary vaccination regimes: vaccination with the minimal intervals permitted by the racing authorities; vaccination in accordance with the manufacturer's instructions and vaccination with the longest intervals permitted by the racing authorities. Study design: Randomised, prospective clinical trial. Methods: The 55 seronegative unvaccinated horses in this study were subdivided by age and randomly allocated one of the 3 vaccination regimes. All groups were sampled each time a group was vaccinated and 3–5 weeks post vaccination. Horses were vaccinated with a subunit immune stimulating complex‐based vaccine (Equip FT ). Antibodies against EI were measured by single radial haemolysis. Results: Lengthening the vaccination intervals increased the immunity gaps between first ( V1 ) and second ( V2 ) doses, and V2 and third dose ( V3 ) but did not inhibit the response to V2 and V3 . The response to V2 and V3 was similar irrespective of the regime. Poor responders to V1 were identified in all age groups included in this study but the greatest number of poor responders was among the yearlings. The 2‐ and 3‐year‐old horses responded better to vaccination than the weanlings or yearlings. Conclusions: Longer vaccination intervals permitted by racing authorities increase the periods of susceptibility to EI but they may facilitate strategic vaccination prior to times of increased risk of exposure to virus. The study provides the type of evidence‐based data necessary to commence meaningful discussion of international harmonisation of EI vaccination requirements.
- 29 January 2014
- Published by Wiley in Equine Veterinary Journal
- Vol. 46 (6) , 669-673
Comparison of primary vaccination regimes for equine influenza: Working towards an evidence‐based regime
Summary: Reasons for performing study: Vaccination is crucial to the control of equine influenza ( EI ). The study was conducted in an effort to lay the groundwork for achieving international harmonisation of regulatory requirements based on scientific evidence of performance of different vaccination regimes. Objectives: To evaluate the effectiveness of 3 different primary vaccination regimes: vaccination with the minimal intervals permitted by the racing authorities; vaccination in accordance with the manufacturer's instructions and vaccination with the longest intervals permitted by the racing authorities. Study design: Randomised, prospective clinical trial. Methods: The 55 seronegative unvaccinated horses in this study were subdivided by age and randomly allocated one of the 3 vaccination regimes. All groups were sampled each time a group was vaccinated and 3–5 weeks post vaccination. Horses were vaccinated with a subunit immune stimulating complex‐based vaccine (Equip FT ). Antibodies against EI were measured by single radial haemolysis. Results: Lengthening the vaccination intervals increased the immunity gaps between first ( V1 ) and second ( V2 ) doses, and V2 and third dose ( V3 ) but did not inhibit the response to V2 and V3 . The response to V2 and V3 was similar irrespective of the regime. Poor responders to V1 were identified in all age groups included in this study but the greatest number of poor responders was among the yearlings. The 2‐ and 3‐year‐old horses responded better to vaccination than the weanlings or yearlings. Conclusions: Longer vaccination intervals permitted by racing authorities increase the periods of susceptibility to EI but they may facilitate strategic vaccination prior to times of increased risk of exposure to virus. The study provides the type of evidence‐based data necessary to commence meaningful discussion of international harmonisation of EI vaccination requirements.
- Open Access
- 14 November 2013
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 7 (s4) , 73-80
The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA)
Background: Antibodies against equine influenza virus (EIV) are traditionally quantified by haemagglutination inhibition (HI) or single radial haemolysis (SRH).Objectives: To evaluate an ELISA for the detection of antibodies against influenza nucleoprotein in the diagnosis and surveillance of equine influenza (EI).Methods: The ELISA was compared with the SRH and HI tests. Serial serum samples from 203 naturally and 14 experimentally infected horses, from 60 weanlings following primary vaccination with five different vaccines (two whole inactivated vaccines, two ISCOM‐based subunit vaccines and a recombinant canarypox virus vaccine) and from 44 adult horses following annual booster vaccination with six different vaccines were analysed.Results: Fewer seroconversions were detected in clinical samples by ELISA than by SRH or HI but ELISA was more sensitive than SRH in naïve foals post‐experimental infection. The ELISA did not detect the antibody response to vaccination with the recombinant canarypox virus vaccine confirming the usefulness of the combination of this kit and vaccine to differentiate between naturally infected and vaccinated horses, that is, DIVA. No DIVA capacity was evident with the other vaccines.Conclusion: The results suggest that this ELISA is a useful supplementary test for the diagnosis of EI although less sensitive than HI or SRH. It is an appropriate test for EI surveillance in a naïve population and may be combined with the recombinant canarypox virus vaccine but not with other commercially available subunit vaccines, in a DIVA strategy.
- 14 November 2013
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 7 (s4) , 73-80
Open AccessThe evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA)
Background: Antibodies against equine influenza virus (EIV) are traditionally quantified by haemagglutination inhibition (HI) or single radial haemolysis (SRH).Objectives: To evaluate an ELISA for the detection of antibodies against influenza nucleoprotein in the diagnosis and surveillance of equine influenza (EI).Methods: The ELISA was compared with the SRH and HI tests. Serial serum samples from 203 naturally and 14 experimentally infected horses, from 60 weanlings following primary vaccination with five different vaccines (two whole inactivated vaccines, two ISCOM‐based subunit vaccines and a recombinant canarypox virus vaccine) and from 44 adult horses following annual booster vaccination with six different vaccines were analysed.Results: Fewer seroconversions were detected in clinical samples by ELISA than by SRH or HI but ELISA was more sensitive than SRH in naïve foals post‐experimental infection. The ELISA did not detect the antibody response to vaccination with the recombinant canarypox virus vaccine confirming the usefulness of the combination of this kit and vaccine to differentiate between naturally infected and vaccinated horses, that is, DIVA. No DIVA capacity was evident with the other vaccines.Conclusion: The results suggest that this ELISA is a useful supplementary test for the diagnosis of EI although less sensitive than HI or SRH. It is an appropriate test for EI surveillance in a naïve population and may be combined with the recombinant canarypox virus vaccine but not with other commercially available subunit vaccines, in a DIVA strategy.
- 14 November 2013
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 7 (s4) , 61-72
Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010–2012)
Background: Outbreaks of equine influenza (EI) in endemic populations cause disruption and economic loss.Objectives: To identify (i) factors involved in the spread of EI (ii) virus strains responsible for outbreaks (iii) single radial haemolysis (SRH) antibody levels correlating with protection against current virus strains (iv) evidence of vaccination breakdown.Methods: RT‐PCR, virus isolation and SRH were carried out on nasopharyngeal swabs and blood samples collected from horses, ponies and donkeys on affected premises. Data relating to 629 samples from 135 equidae were analysed.Results and conclusions: Outbreaks were sporadic, self limiting and associated with the movement of horses. Vaccination status and age influenced clinical signs of disease while housing and fomites contributed to virus spread. Subclinical infection as defined as a horse which tested positive by one or more of the following; RT‐PCR, virus isolation and seroconversion in the absence of clinical signs, was identified in 9% of animals. Of the horses with up to date vaccination records 32% developed clinical signs. Vaccine breakdown occurred among horses vaccinated with all four commercially available vaccines. Analysis of HA1 sequence data generated for 26 viruses indicated that they all belonged to clade 2 of the Florida sublineage. Higher SRH antibody levels were required for both clinical and virological protection than reported in studies where vaccine strains were antigenically and genetically similar to those circulating in the field. The results of this study therefore support the OIE recommendations that vaccines be updated to include representatives of both clades of the Florida sublineage.
- 14 November 2013
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 7 (s4) , 61-72
Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010–2012)
Background: Outbreaks of equine influenza (EI) in endemic populations cause disruption and economic loss.Objectives: To identify (i) factors involved in the spread of EI (ii) virus strains responsible for outbreaks (iii) single radial haemolysis (SRH) antibody levels correlating with protection against current virus strains (iv) evidence of vaccination breakdown.Methods: RT‐PCR, virus isolation and SRH were carried out on nasopharyngeal swabs and blood samples collected from horses, ponies and donkeys on affected premises. Data relating to 629 samples from 135 equidae were analysed.Results and conclusions: Outbreaks were sporadic, self limiting and associated with the movement of horses. Vaccination status and age influenced clinical signs of disease while housing and fomites contributed to virus spread. Subclinical infection as defined as a horse which tested positive by one or more of the following; RT‐PCR, virus isolation and seroconversion in the absence of clinical signs, was identified in 9% of animals. Of the horses with up to date vaccination records 32% developed clinical signs. Vaccine breakdown occurred among horses vaccinated with all four commercially available vaccines. Analysis of HA1 sequence data generated for 26 viruses indicated that they all belonged to clade 2 of the Florida sublineage. Higher SRH antibody levels were required for both clinical and virological protection than reported in studies where vaccine strains were antigenically and genetically similar to those circulating in the field. The results of this study therefore support the OIE recommendations that vaccines be updated to include representatives of both clades of the Florida sublineage.
- 1 November 2013
- Published by Elsevier in Veterinary Microbiology
- Vol. 167 (1-2) , 205-214
Equine influenza—A global perspective
- 1 November 2013
- Published by Elsevier in Veterinary Microbiology
- Vol. 167 (1-2) , 205-214
Equine influenza—A global perspective
- Open Access
- 1 March 2013
- Published by Microbiology Society in Journal of General Virology
- Vol. 94 (3) , 612-622
Genetic characterization by composite sequence analysis of a new pathogenic field strain of equine infectious anemia virus from the 2006 outbreak in Ireland
Equine infectious anemia virus (EIAV), the causative agent of equine infectious anaemia (EIA), possesses the least-complex genomic organization of any known extant lentivirus. Despite this relative genetic simplicity, all of the complete genomic sequences published to date are derived from just two viruses, namely the North American EIAVWYOMING(EIAVWY) and Chinese EIAVLIAONING(EIAVLIA) strains. In 2006, an outbreak of EIA occurred in Ireland, apparently as a result of the importation of contaminated horse plasma from Italy and subsequent iatrogenic transmission to foals. This EIA outbreak was characterized by cases of severe, sometimes fatal, disease. To begin to understand the molecular mechanisms underlying this pathogenic phenotype, complete proviral genomic sequences in the form of 12 overlapping PCR-generated fragments were obtained from four of the EIAV-infected animals, including two of the index cases. Sequence analysis of multiple molecular clones produced from each fragment demonstrated the extent of diversity within individual viral genes and permitted construction of consensus whole-genome sequences for each of the four viral isolates. In addition, completeenvgene sequences were obtained from 11 animals with differing clinical profiles, despite exposure to a common EIAV source. Although the overall genomic organization of the Irish EIAV isolates was typical of that seen in all other strains, the European viruses possessed ≤80 % nucleotide sequence identity with either EIAVWYor EIAVLIA. Furthermore, phylogenetic analysis suggested that the Irish EIAV isolates developed independently of the North American and Chinese viruses and that they constitute a separate monophyletic group.
- 1 March 2013
- Published by Microbiology Society in Journal of General Virology
- Vol. 94 (3) , 612-622
Open AccessGenetic characterization by composite sequence analysis of a new pathogenic field strain of equine infectious anemia virus from the 2006 outbreak in Ireland
Equine infectious anemia virus (EIAV), the causative agent of equine infectious anaemia (EIA), possesses the least-complex genomic organization of any known extant lentivirus. Despite this relative genetic simplicity, all of the complete genomic sequences published to date are derived from just two viruses, namely the North American EIAVWYOMING(EIAVWY) and Chinese EIAVLIAONING(EIAVLIA) strains. In 2006, an outbreak of EIA occurred in Ireland, apparently as a result of the importation of contaminated horse plasma from Italy and subsequent iatrogenic transmission to foals. This EIA outbreak was characterized by cases of severe, sometimes fatal, disease. To begin to understand the molecular mechanisms underlying this pathogenic phenotype, complete proviral genomic sequences in the form of 12 overlapping PCR-generated fragments were obtained from four of the EIAV-infected animals, including two of the index cases. Sequence analysis of multiple molecular clones produced from each fragment demonstrated the extent of diversity within individual viral genes and permitted construction of consensus whole-genome sequences for each of the four viral isolates. In addition, completeenvgene sequences were obtained from 11 animals with differing clinical profiles, despite exposure to a common EIAV source. Although the overall genomic organization of the Irish EIAV isolates was typical of that seen in all other strains, the European viruses possessed ≤80 % nucleotide sequence identity with either EIAVWYor EIAVLIA. Furthermore, phylogenetic analysis suggested that the Irish EIAV isolates developed independently of the North American and Chinese viruses and that they constitute a separate monophyletic group.
- 6 October 2011
- Published by Wiley in Equine Veterinary Journal
- Vol. 44 (4) , 387-392
The molecular epidemiology of equine influenza in Ireland from 2007–2010 and its international significance
Summary: Reasons for performing the study: Antigenic and genetic drift of equine influenza (EI) virus is monitored annually by the Expert Surveillance Panel (ESP), which make recommendations on the need to update vaccines. Surveillance programmes are essential for this process to operate effectively and to decrease the risk of disease spread through the international movement of subclinically infected vaccinated horses. Not only is surveillance necessary to inform vaccine companies which strains are in circulation, but it serves as an early warning system for horse owners, trainers and veterinary clinicians, facilitating the implementation of appropriate prophylactic and control measures. Objective: To summarise the genetic analysis of EI viruses detected in Ireland from June 2007 to January 2010. Methods: The HA1 gene of 18 viruses was sequenced and phylogenetic analysis undertaken. Results: All viruses belonged to the Florida sublineage of the American lineage. Clade 2 viruses predominated up to 2009. The viruses identified on 4 premises in 2007 displayed 100% nucleotide identity to A/eq/Richmond/1/07, the current clade 2 prototype. The first clade 1 virus was identified in November 2009 and, thereafter, clade 1 viruses were responsible for all the outbreaks identified. The Irish clade 1 viruses differ from the clade 1 virus responsible for the EI outbreaks in Japan and Australia in 2007. No virus of the Eurasian lineage was isolated during this surveillance period. Conclusions: In 2010 the ESP recommended that the vaccines should not include a H7N7 virus or a H3N8 virus of the Eurasian lineage but that they should contain both a clade 1 and clade 2 virus of the Florida sublineage. The surveillance data presented here support these recommendations and indicate that they are epidemiologically relevant. Potential relevance: These data also serve as a scientific basis for investigating the source of epizootics and outbreaks both nationally and internationally.
- 6 October 2011
- Published by Wiley in Equine Veterinary Journal
- Vol. 44 (4) , 387-392
The molecular epidemiology of equine influenza in Ireland from 2007–2010 and its international significance
Summary: Reasons for performing the study: Antigenic and genetic drift of equine influenza (EI) virus is monitored annually by the Expert Surveillance Panel (ESP), which make recommendations on the need to update vaccines. Surveillance programmes are essential for this process to operate effectively and to decrease the risk of disease spread through the international movement of subclinically infected vaccinated horses. Not only is surveillance necessary to inform vaccine companies which strains are in circulation, but it serves as an early warning system for horse owners, trainers and veterinary clinicians, facilitating the implementation of appropriate prophylactic and control measures. Objective: To summarise the genetic analysis of EI viruses detected in Ireland from June 2007 to January 2010. Methods: The HA1 gene of 18 viruses was sequenced and phylogenetic analysis undertaken. Results: All viruses belonged to the Florida sublineage of the American lineage. Clade 2 viruses predominated up to 2009. The viruses identified on 4 premises in 2007 displayed 100% nucleotide identity to A/eq/Richmond/1/07, the current clade 2 prototype. The first clade 1 virus was identified in November 2009 and, thereafter, clade 1 viruses were responsible for all the outbreaks identified. The Irish clade 1 viruses differ from the clade 1 virus responsible for the EI outbreaks in Japan and Australia in 2007. No virus of the Eurasian lineage was isolated during this surveillance period. Conclusions: In 2010 the ESP recommended that the vaccines should not include a H7N7 virus or a H3N8 virus of the Eurasian lineage but that they should contain both a clade 1 and clade 2 virus of the Florida sublineage. The surveillance data presented here support these recommendations and indicate that they are epidemiologically relevant. Potential relevance: These data also serve as a scientific basis for investigating the source of epizootics and outbreaks both nationally and internationally.